Skip to main content
logo
Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.865
+0.005 (0.27%)
Aug 7, 2026, 2:54 PM EDT - Market open

Annovis Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14.2219.5310.555.7528.3845.69
Cash & Short-Term Investments
14.2219.5310.555.7528.3845.69
Cash Growth
-36.05%85.11%83.36%-79.72%-37.89%465.79%
Other Current Assets
2.021.553.374.457.640.32
Total Current Assets
16.2421.0813.9310.2136.0246
Total Assets
16.2421.0813.9310.2136.0246

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.282.592.311.293.960.69
Accrued Expenses
7.511.041.582.993.740.82
Total Current Liabilities
12.793.643.884.287.71.51
Other Long-Term Liabilities
0.330.60.7413.68--
Total Long-Term Liabilities
0.330.60.7413.68--
Total Liabilities
13.124.234.6217.967.71.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-in Capital
184.43180.55144.16102.5182.3873.22
Retained Earnings
-181.31-163.7-134.85-110.26-54.05-28.73
Shareholders' Equity
3.1316.859.31-7.7528.3244.49
Total Liabilities & Equity
16.2421.0813.9310.2136.0246

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
14.2219.5310.555.7528.3845.69
Net Cash Growth
-36.05%85.11%83.36%-79.72%-37.89%465.79%
Net Cash Per Share
0.610.950.860.643.485.99
Book Value
3.1316.859.31-7.7528.3244.49
Book Value Per Share
0.130.820.76-0.863.475.83
Tangible Book Value
3.1316.859.31-7.7528.3244.49
Tangible Book Value Per Share
0.130.820.76-0.863.475.83
SEC Filings: 10-K · 10-Q